Portfolio Overview & Capital Allocation
Private large
portfolio companies
EXTERNALLY VALUED
ӨӨ
08 RETAIL (PHARMACY) BUSINESS OVERVIEW (CONT'D)
Margin enhancement and strong
growth in para-pharmacy sales
Strong sales in para-pharmacy products of
GEL 186.3 million in 2020 (up 29.7% y-o-y),
with 31.4% gross profit margin.
Para-pharmacy sales have the strongest
margins and the share of para-pharmacy
sales in retail revenue reached 34.7% in
2020 (31.0% in 2019).
FY20 CASH FLOW
HIGHLIGHTS
REVENUE
GEORGIA
CAPITAL
AVERAGE BILL SIZE & NUMBER OF BILLS ISSUED
Gross profit margin (%)
24.5%
25.5%
25.5%
25.4%
26.0% 24.2%
Number of bills issued, million
25.3
27.1
28.8
27.6
+10.5%
Same store growth (%)
NMF
9%
9%
6%
800
679.4
614.7
GEL million
600
518.6
184.7
450.3
176.9
+16.4%
134.5
400
113.9
GEL
16.8
14.3
13.3
13.4
201.0
494.7
172.7
200
437.8
336.4
384.1
58.7
49.7
123.0
142.3
0
2017
2018
2019
2020
4Q19
4Q20
■Retail
Distribution
Number of pharmacies
countrywide
255
270
296
309
EBITDA¹
2017
2018
2019
CUSTOMER INTERACTIONS PER MONTH
GEL 66.1m
+24.4% y-o-y
Operating leverage¹(%)
Operating cash flow¹
NMF
7.8%
4.1%
-1.4%
4.1%
-1.9%
c.0.8mln
EBITDA margin¹ (%)
93.9%
8.6%
10.1%
10.6%
10.4%
11.1% 10.1%
Loyal customers
+12.5ppts y-o-y
EBITDA to cash conversion¹
GEL 60.8m
+27.7% y-o-y
Free cash flow¹
Georgia Capital PLC | 1. Excluding IFRS16 impact
GEL million
150
100
+7.8%
70.4
65.3
52.2
38.9
50
+6.0%
19.2
20.3
million
20
10
2020
2.1
2.3
2.4
2.3
0
0
2017
2018
2019
2020
4Q19
4Q20
2017
2018
2019
2020
50View entire presentation